Thomas L.The Youngest Science. New York: Penguin, 1995; 149—158.
2.
Thomas L., Good RAStudies on the generalized Shwartzman reaction. I. General observations concerning the phenomenon. J Exp Med1952; 96: 605—625.
3.
Bennett Jr ILApproaches to the mechanisms of endotoxin action. In: Landy M, Braun W. (eds) Bacterial Endotoxins. Proceedings of a symposium held at the Institute of Microbiology of Rutgers, the State University, New Brunswick, NJ, 1964; xiii—xvi.
4.
Hartwell JL, Shear MJ, Adams Jr JRChemical treatment of tumors. VII. Nature of hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J Natl Cancer Inst1943; 4: 107—122.
5.
Beeson PBTolerance to bacterial pyrogens. I. Factors influencing its development. J Exp Med1947; 86: 29—38.
6.
Mackensen A., Galanos C., Wehr U., Engelhardt R.Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw1992; 3: 571—579.
7.
Engelhardt R. , Otto F., Mackensen A., Mertelsmann R., Galanos C.Endotoxin (Salmonella abortus equi) in cancer patients. Clinical and immunological findings. Prog Clin Biol Res1995; 392: 253—261.
8.
Beeson PBTolerance to bacterial pyrogens. II. Role of the reticulo-endothelial system . J Exp Med1947: 86: 39—44.
9.
Beeson PBTemperature-elevating effect of a substance obtained from polymorphonuclear leukocytes [Abstract]. J Clin Invest1948; 27: 524.
10.
Wharton Dra , Creech HJFurther studies on the immunological properties of polysaccharides from Serratia marcescens (Bacillus prodigiosus). II. Nature of the antigenic action and the antibody response in mice. Cancer Res1949; 62: 135—153.
11.
Biozzi GB, Benacerraf B., Halpern BN, Stiffel C., Mouton D.The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection. Br J Exp Pathol1959; 40: 281—290.
12.
Howard JG, Rowley D., Wardlaw ACInvestigations on the mechanism of stimulation of non-specific immunity by bacterial lipopolysaccharide. Immunology1958 ; 1: 181—203.
13.
Rowley D.Stimulation of natural immunity to Escherichia coli infections. Lancet1955; 268: 232—234.
14.
Braude AI, Siemenski J.The influence of endotoxin on resistance to infection. Bull NY Acad Med1961; 37: 448—467.
Griesman SE, Hornick RBMechanisms of endotoxin tolerance with special reference to man. In: Kass EH, Wolff SM. (eds) Bacterial Lipopolysaccharide: The Chemistry, Biology and Clinical Significance of Endotoxins. Chicago; IL: University of Chicago Press, 1973; 257—268.
17.
Hill AW, Hibbitt KG, Shears A.Endotoxin tolerance and the induction of nonspecific resistance to Salmonella dublin and Streptococcus agalactiae infections in mice. Br J Exp Pathol1974; 55: 269—274.
18.
Greisman SE , Young EJ, Workman JB, Ollodart RM, Hornick RBMechanisms of endotoxin tolerance. The role of the spleen. J Clin Invest1975; 56: 1597—1607.
19.
Lindberg AA , Greisman SE, Svenson SBInduction of endotoxin tolerance with nonpyrogenic0-antigen oligosaccharide-protein conjugates. Infect Immun1983; 41: 888—895.
20.
Hook EW, Wagner RRResistance promoting activity of endotoxins and other microbial products. II. Protection against neurotoxic action of products of influenza virus. J Immunol1959; 83: 310—317.
21.
Zweifach BW , Thomas L.Relationship between vascular manifestations of shock produced by endotoxin, trauma and hemorrhage. II. Possible role ofreticulo-endothelial system in resistance to each type of shock. J Exp Med1957; 106: 403—414.
22.
Smith WW, Alderman IM, Gillespie REResistance to experimental infection and mobilization of granulocytes in irradiated mice treated with bacterial endotoxin. Am J Physiol1958; 192: 263—267.
23.
Greisman SE , Carozza Jr FA, Hills JD. Mechanisms of endotoxin tolerance. I. Relationship between tolerance and reticuloendothelial system phagocytic activity in the rabbit. J Exp Med1963; 117: 663—674.
24.
Wolff SMBiological effects of bacterial endotoxin in man. In: Kass EH, Wolff SM. (eds) Bacterial Lipopolysaccharide: The Chemistry, Biology and Clinical Significance of Endotoxins. Chicago; IL: University of Chicago Press, 1973; 251—256.
25.
Greisman SE , DuBuy B.Mechanisms of endotoxin tolerance. IX. Effect of exchange transfusion. Proc Soc Exp Biol Med1975; 148: 675—678.
26.
Goodman JS, Rogers DE, Koenig MGThe hepatic uptake of bacterial endotoxin. I. The influence of humoral and cellular factors. Proc Soc Exp Biol Med1969 ; 132: 372—375.
27.
Dinarello CA , Bodel PT, Atkins E.The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc Am Physicians1968; 81: 334—344.
28.
Greisman SE , Woodward CLMechanisms of endotoxin tolerance. VII. The role of the liver. J Immunol1970; 105: 1468—1476.
29.
Griesman SE , Hornick RB, Wagner Jr HN, Woodward WE, Woodward TEThe role of endotoxin tolerance during typhoid fever and tularemia in man. IV. Integrity of endotoxin tolerance mechanisms during infection. J Clin Invest1969; 48: 613—629.
30.
McCabe WREndotoxin tolerance. II. Its occurrence in patients with pyelonephritis. J Clin Invest1963; 42: 618—625.
31.
Neva FA, Morgan HRTolerance to the action of endotoxins of enteric bacilli in patients convalescent from typhoid and paratyphoid fevers. J Lab Clin Med1950; 35: 911—915
32.
Heyman A., Beeson PBInfluence of various disease states upon the febrile response to intravenous injection of typhoid bacterial pyrogen. J Lab Clin Med1949; 34: 1400—1403.
33.
Greisman SE , Hornick RB, Carozza Jr FA, Woodward TE. The role of endotoxin during typhoid fever and tularemia in man. I. Acquisition of tolerance to endotoxin. J Clin Invest1963; 42: 1064—1075.
Page AR, Good RAStudies on cyclic neutropenia. Am J Dis Child1957; 94: 623—661.
36.
Rafter GW, Collins RD, Wood Jr WBStudies on the pathogenesis of fever. VII. Preliminary chemical characterization of leucocytic pyrogen. J Exp Med1960; 111: 831—841.
37.
Bodel PT, Atkins E.Release of endogenous pyrogen by human monocytes. N Engl J Med1967; 276: 1002—1008.
38.
Ho M., Kono Y., Breinig MKTolerance to the induction of interferons by endotoxin and viruses: role of a humoral factor. Proc Soc Exp Biol Med1965 ; 119: 1227—1232.
39.
Youngner JS , Stinebring WRInterferon appearance stimulated by endotoxin, bacteria or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis. Nature1965; 208: 456—458.
40.
Absher M., Stinebring WRToxic properties of a synthetic double-stranded RNA. Endotoxin-like properties of poly I:poly C, an interferon. Nature1969 ; 223: 715—717.
41.
Giron DJ, Schmidt JP, Pindak FF, Connell JEInterferon tolerance and antiviral protection in mice given single or multiple injection of endotoxin or poly I:C. Acta Virol1973; 17: 209—214.
42.
Quesenberry P. , Halperin J., Ryan M., Stohlman Jr F.Tolerance to the granulocyte-rel easing and colony-stimulating elevating effects of endotoxin. Blood1975; 45: 789—800.
43.
Sullivan R., Gans PJ, McCarroll LAThe synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocyte kinetics of response to bacterial endotoxin . J Immunol1983; 130: 800—807.
44.
Madonna GS, Vogel SNEarly endotoxin tolerance is associated with alterations in both marrow-derived macrophages precursor pools. J Immunol1985 ; 135: 3763—3771.
45.
Vogel SN, Kaufman EN, Tate MD, Neta R.Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun1988; 56: 2650—2657.
46.
Henricson BE, Neta R., Vogel SNAn interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun1991; 59: 1188—1191.
47.
Greer GG, Rietschel ETLipid A-induced tolerance and hyper-reactivity to hypothermia in mice. Infect Immun1978; 19: 357—368.
48.
Galelli A., Chedid L.Induction of colony-stimulating activity (CSA) by a synthetic muramyl peptide (MDP): synergism with LPS and activity in C3H/HeJ mice and in endotoxin-tolerized mice. J Immunol1986; 137: 3211—3215.
49.
Zeisberger E., Roth J.Tolerance to pyrogens. Ann NY Acad Sci1998; 856: 116—131.
50.
Boehme D., Dubos RJEffects of bacterial constituents on resistance of mice to heterologous infection and on activity of their reticulo-endothelial system. J Exp Med1958; 107: 523—536.
51.
Benacerraf B., Thorbecke GJ, Jacoby D.Effect of zymosan on endotoxin toxicity in mice. Proc Soc Exp Biol Med1959; 100: 796—799.
52.
Greer GG, Rietschel ETInverse relationship between the susceptibility of lipopolysaccharide (lipid A)-pretreated mice to the hypothermic and lethal affect of lipopolysaccharide . Infect Immun1978; 20: 366—374.
53.
Mathison JC , Virca GD, Wolfson E., Tobias PS, Glaser K., Ulevitch RJAdaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest1990; 85: 1108—1118.
54.
Zuckerman SH , Evans GF, Butler LDEndotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun1991; 59: 2774—2780.
55.
Mengozzi M. , Fantuzzi G., Sironi M. et al. Early downregulation of TNF production by LPS tolerance in human monocytes. Comparison with IL-1β, IL-6 and IL-8 . Lymphokine Cytokine Res1993; 12: 231—236.
56.
Tominaga K. , Saito S., Matsuura M., Nakano M.Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-kappaB cascades, but not lipopolysaccharide-incorporation steps. Biochim Biophys Acta1999; 1450: 130—144.
57.
Coffee KA, Halushka PV, Ashton SH, Tempel GE, Wise WC, Cook JAEndotoxin tolerance is associated with altered GTPbinding protein function . J Appl Physiol1992; 73: 1008—1013.
58.
Fernando LP , Makhlouf M., Fernando AN, Ashton S., Halushka PV, Cook JATolerance to LPS decreases macrophage G protein content. Shock1999; 11: 330—335.
59.
Kraatz J., Clair L., Rodriguez JL, West MAMacrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK . J Surg Res199983: 158—164.
60.
Heagy W., Hansen C., Nieman K., Rodriguez JL, West MAImpaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-toleranthuman monocytes. J Trauma2000; 49: 806—814.
61.
Zuckerman SH , Evans GFEndotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol1992; 140: 513—519.
62.
Takasuka N. , Matsuura K., Yamamoto S., Akagawa KSSuppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression. J Immunol1995; 154: 4803—4812.
63.
Kohler NG, Joly A.The involvement of an LPS inducible I kappa B kinase in endotoxin tolerance . Biochem Biophys Res Commun1997; 232: 602—607.
64.
Blackwell TS , Blackwell TR, Christman JWInduction of endotoxin tolerance depletes nuclear factor-kappaB and suppresses its activation in rat alveolar macrophages . J Leukoc Biol1997; 62: 885—891.
65.
Randow F., Syrbe U., Meisel C. et al. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med1995; 181: 1887—1892.
66.
Learn CA, Mizel SB, McCall CEmRNA and protein stability regulate the differential expression of pro- and anti-inflammatory genes in endotoxin-tolerantTHP-1 cells. J Biol Chem2000; 275: 12185—12193.
67.
Kastenbauer S., Ziegler-Heitbrock HWNF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression . Infect Immun1990; 67: 1553—1559.
68.
Wahlstrom K. , Bellingham J., Rodriguez JL, West MAInhibitory kappaB alpha control of nuclear factor-kappaB is dysregulated in endotoxin tolerant macrophages. Shock1999; 11: 242—247.
Shames BD, Meldrum DR, Selzman CH et al. Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol1998; 275: H1084—H1091.
71.
Goldring CE , Reveneau S., Pinard D., Jeannin JFHyporesponsiveness to lipopolysaccharide alters the composition of NF-kappa B binding to the regulatory regions of inducible nitric oxide synthase gene. Eur J Immunol1998; 28: 2960—2970.
72.
Fujihara M. , Wakamoto S., Ito T. et al. Lipopolysaccharide-triggered desensitization of TNF-alpha mRNA expression involves lack of phosphorylation of IkappaBalpha in a murine macrophage-like cell line, P388D1. J Leukoc Biol2000; 68: 267—276.
73.
Freudenberg MA, Galanos C.Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages . Infect Immun1988; 56: 1352—1357.
74.
Dinarello CA , Cannon JG, Wolff SM et al. Tumor necrosis factor (cachectin) is a endogenous pyrogen induces production of interleukin 1. J Exp Med1986; 163: 1433—1450.
75.
Munoz C., Carlet J., Fitting C., Misset B., Bleriot J-P., Cavaillon J-M.Dysregulation of the in vitro cytokineproductionby monocytes during sepsis . J Clin Invest1991; 88: 1747—1754.
76.
Ertel W., Keel M., Neidhardt R. et al. Inhibition of the defense system stimulating interleukin 12 interferon γ pathway during critical illness. Blood1997; 89: 1612—1620.
77.
Van Deuren M., Van Der Ven-Jongekrijg H., Demacker Pnm et al. Differential expression of pro-inflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis1994; 169: 157—161.
78.
Marchant A. , Alegre M., Hakim A. et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol1995; 15: 265—272.
79.
Mengozzi M., Sironi M., Gadina M., Ghezzi P.Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J Immunol1991 ; 147: 899—902.
80.
Ackermann M., Reuter M., Flohe S., Bahrami S., Redl H., Schade FUCytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J Endotoxin Res2001; 7: 105—112.
81.
Quesenberry P. , Cohen H., Levin J., Sullivan R., Bealmear P., Ryan M.Effects of bacterial infection and irradiation on serum colony-stimulating factor levels in tolerant and nontolerant C mice . Blood1978; 51: 229—244.
82.
Flohe S., Heinrich PC, Schneider J., Wendel A., Flohe L.Time course of IL-6 and TNF alpha release during endotoxin-induced endotoxin tolerance in rats. Biochem Pharmacol1991; 41: 1607—1614.
83.
Erroi A., Fantuzzi G., Mengozzi M. et al. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect Immun1993; 61: 4356—4359.
84.
Ziegler Heitbrock HW, Blumenstein M., Kafferlein E. et al. In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology1992; 75: 264—268.
85.
Rieser C., Papesh C., Herold M. et al. Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2 . Blood1998; 91: 3112—3117.
86.
Kaufmann A. , Gemsa D., Sprenger H.Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur J Immunol2000; 30: 1562—1567.
87.
Lehner MD, Ittner J., Bundschuh DS, van Rooijen N., Wendel A., Hartung T.Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun2001; 69: 463—471.
88.
Astiz ME, Rackow EC, Still JG et al. Pretreatment of normal humans with monophosphoryllipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med1995; 23: 9—17.
89.
Rayhane N., Fitting C., Cavaillon J-M.Disociation of IFN-γ from IL-12 and IL-18 production during endotoxin tolerance. J Endotoxin Res1999; 5: 319—324.
90.
Karp CL, Wysocka M., Ma X. et al. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol1998; 28: 3128—3136.
91.
Wysocka M., Robertson S., Riemann H. et al. IL-12 suppression during experimental endotoxin tolerance: dendritic cells loss and macrophage hyporesponsiveness. J Immunol2001; 166: 7504—7513.
92.
Varma TK, Toliver-Kinsky TE, Lin CY, Koutrouvelis AP, Nichols JE, Sherwood ERCellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun2001; 69: 5249—5263.
93.
Frankenberger M., Pechumer H., Ziegler-Heitbrock HWInterleukin-10 is upregulated in LPS tolerance. J Inflamm1995; 45: 56—63.
94.
van derPoll T., Coyle SM, Moldawer LL, Lowry SFChanges in endotoxin-induced production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis1996; 174: 1356—1360.
95.
Berg DJ, Kuhn R., Rajewsky K. et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest1995; 96: 2339—2347.
96.
Wolk K., Docke W., von Baehr V., Volk H., Sabat R.Comparison of monocyte functions after LPS-or IL-10-induced re-orientation: importance in clinical immunoparalysis. Pathobiology1999: 67: 253—256.
97.
Fraker DL, StovroffMC, Merino MJ, Norton JA. Tolerance to tumor necrosis factor in rats and the relationship endotoxin tolerance and toxicity. J Exp Med1988; 168: 95—105.
98.
Medvedev AE , Kopydlowski KM, Vogel SNInhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol2000; 164: 5564—5574.
99.
Haas JG, Meyer N., Riethmuller G., Ziegler-Heitbrock HWInhibition of lipopolysaccharide-induced in vitro desensitization by interferon-gamma . Eur J Immunol1990; 20: 1181—1184.
100.
Randow F., Docke WD, Bundschuh DS, Hartung T., Wendel A., Volk HDIn vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12 and granulocyte-macrophage colony-stimulating factor. J Immunol1997; 158: 2911—2918.
101.
Bundschuh DS , Barsig J., Hartung T. et al. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol1997; 158: 2862—2871.
102.
Kawasaki H. , Moriyama M., Ohtani Y., Naitoh M., Nariuchi H., Tanaka A.Restoration of normal febrile response to endotoxin in progen-tolerant rabbits by injection with human beta interferon . Infect Immun1987; 55: 2574—2578.
103.
West MA, LeMieur T., Clair L., Bellingham J., Rodriguez JLProtein kinase C regulates macrophages tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery1997; 122: 204—211.
104.
Virca GD, Kim SY, Glaser KB, Ulevitch RJLipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. JBiol Chem1989; 264: 21951—21956.
105.
Roth J., Aslan T., Storr B., Zeisberger E.Lack of cross-tolerance between LPS and muramyl dipeptide in induction of circulating TNF-α and IL-6 in guinea pigs. Am J Physiol1997; 273: R1529—R1533.
106.
Riedel DD, Kaufmann SHDifferential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages. Microb Infect2000; 2: 463—471.
107.
Crabtree TD , Jin L., Raymond DP et al. Pre-exposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect Immun2001; 69: 2123—2129.
108.
MedvedevAE, Henneke P., Schromm A. et al. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J Immunol2001 ; 167: 2257—2267.
109.
Lehner MD, Morath S., Michelsen KS, Schumann RR, Hartung T.Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators . J Immunol2001; 166: 5161—5167.
110.
Sato S., Nomura F., Kawai T. et al. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol2000; 165: 7096—7101.
111.
Cavaillon J-M. , Pitton C., Fitting C.Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGF-β. J Endotoxin Res1994; 1: 21—29.
112.
Baykal A., Kaynaroglu V., Hascelik G., Sayek I., Sanac Y.Epinephrine and endotoxin tolerance differentially modulate serum cytokine levels to high-dose lipopolysaccharide challenge in a murine model. Surgery1999; 125: 403—410.
113.
Cross AS, Opal SM, Sadoff JC, Gemski P.Choice of bacteria in animal models of sepsis. Infect Immun1993; 61: 2741—2747.
114.
Werner AS, Cobbs CG, Kaye D., Hook EWStudies on the bacteremia of bacterial endocarditis. JAMA1967; 202: 127—131.
115.
Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DFSerial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial septicemia. J Infect Dis1988; 157: 565—568.
116.
Senterfitt VC , Shands Jr JW. Salmonellosis in mice infected with Mycobacterium tuberculosis BCG. I Role of endotoxin in infection. J Bacteriol1968; 96: 287—292.
117.
Cowdery JS, Chace JH, Yi AK, Krieg AMBacterial DNA induces NK cells to produce interferon γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol1996; 156: 4570—4575.
118.
Gao JJ, Xue Q., Papasian CJ, Morrison DCBacterial DNA and lipopolysaccharide induce synergistic production of TNF-α through a post-transcriptional mechanism. J Immunol2001; 166: 6855—6860.
119.
Aderem A.Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med2001; 29 (Suppl 7): S16—S18.
120.
Wilkinson MF, Kasting NWCentrally acting vasopressin contributes to endotoxin tolerance. Am J Physiol1990; 258: R443—R449.
121.
Freedman HHFurther studies on passive transfer of tolerance to pyrogenicity of bacterial endotoxin. J Exp Med1960; 88: 619—634.
122.
Morgan HRResistance to the action of enteric bacilli in man. J Clin Invest1948; 27: 706—709.
123.
Griesman SE , Wagner Jr HN, Iio M., Hornick RBMechanism of endotoxin tolerance and reticuloendothelial system phagocytic activity in man. J Exp Med1964; 119; 241—264.
124.
Labeta MO, Durieux JJ, Spagnoli G., Fernandez N., Wijdenes J., Herrmann R.CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis . Immunology1993; 80: 415—423.
125.
Larsen NE, Sullivan R.Interaction between endotoxin and human monocytes: characteristic of the binding of 3H-labeled lipopolysaccharide51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci USA1984; 81: 3491—3495.
126.
Sullivan R. , LipkinEW, Bell R, Larsen NE, McCarroll LA. The kinetics of the production of granulocyte-monocyte colon stimulating activity (GM-CSA) by isolated human monocytes response to bacterial endotoxin. Prog Clin Biol Res1985; 184: 173—187.
127.
Nomura F., Akashi S., Sakao Y. et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface Toll-like receptor 4 expression . J Immunol2000; 164: 3476—3479.
128.
Galanos C. , Freudenberg MA, Matsuura M., Coumbos A.Hypersensitivity to endotoxin and mechanisms of host-response. Prog Clin Biol Res1988; 272: 295—308.
129.
Williams Z. , Hertogs CF, Pluznik DHUse of mice tolerant to lipopolysaccharide to demonstrate requirement of co-operation between macrophages and lymphocyte to generate lipopolysaccharide-induced colony-stimulatingfactor in vivo. Infect Immun1983; 41: 1—5.
130.
Madonna GS , Vogel SNInduction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice . Infect Immun1986; 53: 707—710.
131.
Ogle CK, Arita H., Nagy H. et al. The immunosuppressive effects of the in vivo administration of endotoxin as influenced by macrophages. J Trauma1989; 29: 1015—1020.
132.
Otto F., Schmid P., Mackensen A. et al. Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur J Cancer1996; 32A: 1712—1718.
133.
Wolk K., Docke WD, von Baehr V., Volk HD, Sabat R.Impaired antigen presentation by human monocytes during endotoxin tolerance . Blood2000; 96: 218—223.
134.
Lush CW, Cepinskas G., Kvietys PRLPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-kappaB mobilization. Am J Physiol2000; 278: H853—H861.
135.
McCall CE, Grosso-Wilmoth LM, LaRue K., Guzman RN, Cousart SLTolerance to endotoxin-induced expression of the interleukin 1-β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest1993; 91; 853—861.
136.
Marie C., Muret J., Fitting C., Losser MR, Payen D., Cavaillon J-M.Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood1998; 91; 3439—3446.
137.
Granowitz EV, Porat R., Mier JW et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans . J Immunol1993: 151: 1637—1645.
138.
Flohe S., Dominguez Fernandez E., Ackermann M., Hirsch T., Borgermann J., Schade FUEndotoxin tolerance in rats: expression of TNF-alpha, IL-6 IL-10, VCAM-1 and HSP 70 in lung and liver during endotoxin shock. Cytokine1999; 11: 796—804.
139.
Salkowski CA, Detore G., Franks A., Falk MC, Vogel SNPulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryllipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration . Infect Immun1998; 66: 3569—3578.
140.
Faggioni R. , Fantuzzi G., Villa P., Buurman W., van Tits LJ, Ghezzi P.Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun1995; 63: 1473—1477.
141.
Ivanov AI, Kulchitsky VA, Sugimoto N., Simons CT, Romanovsky AADoes the formation of lipopolysaccharide tolerance require intact vagal innervation of the liver? AutonNeurosci2000; 85: 111—118.
Almedia MC , Trevisan FN, Barros RC, Carnio EC, Branco LGTolerance to lipopolysaccharide is related to the nitric oxide pathway. Neuroreport1999 : 10: 3061—3065.
144.
Fukuda T., Hata N., Okuma H.Increased resistance to epinephrine infusion in endotoxin-tolerance state . Jpn J Physiol1969; 19: 143—148.
145.
Haider R.Endotoxin fever and tolerance in totally adrenalectomized rats. Proc Soc Exp Biol Med1971; 136: 514—517.
Warren HS, Knights CV, Siber GRNeutralization and lipoprotein binding of lipopolysaccharide tolerant rabbit serum. J Infect Dis1986; 154: 784—791.
148.
Kitchens RL , ThompsonPA, Viriyakosol S, O'Keefe GE, Munford RS. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest2001; 108: 485—493.
149.
Christman JW , Lancaster LH, Blackwell TSNuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med1998; 24: 1131—1138.
150.
Rayhane N. , Fitting C., Lortholary O., Dromer F., Cavaillon J-M.Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun2000; 68: 3748—3753.
151.
McCuskey RS, Urbaschek R., McCuskey PA, Urbaschek B.In vivo microscopic observations of the responses of Kupffer cells and the hepatic microcirculation to Mycobacterium bovis BCG alone and in combination with endotoxin. Infect Immun1983; 42: 362—367.
152.
Madonna GS, Peterson JE, Ribi EE, Vogel SNEarly-phase endotoxin tolerance: induction by a detoxified lipid derivative, monophosphoryllipid A. Infect Immun1986; 52: 6—11.
153.
Kiani A., Tschiersch A., Gaboriau E. et al. Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients . Blood1997; 90: 1673—1683.
154.
Christ W., Asano O., Robidoux AL et al. E5531, a pure endotoxin antagonist of high potency. Science1995; 268: 80—83.
155.
Cross AS, Asher L., Seguin M. et al. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against experimentally invasive Escherichia coli. J Clin Invest1995; 96: 676—686.
156.
Cross AS, Sadoff JC, Kelly N., Bernton E., Gemski P.Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection . J Exp Med1989; 169: 2021—2027.
157.
Ziegler-Heitbrock HW, Frankenberger M., Wedel A.Tolerance to lipopolysaccharide in human blood monocytes. Immunobiology1995; 193: 217—223.
158.
Ziegler-Heitbrock HW, Wedel A., Schraut W. et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers . J Biol Chem1994; 269: 17001—17004.
159.
Matic M., Simon SREffects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infect Immun1992; 60: 3756—3762.
160.
Barber SA, Fultz MJ, Salkowski CA, Vogel SNDifferential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS hyporesponsive macrophages. Infect Immun1995; 63: 601—608.
161.
Szabo C., Theimermann C., Wu CC, Perretti M., Vane JRAttenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA1994; 91: 271—275.
162.
Severn A., Xu D., Doyle J. et al. Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity . Eur J Immunol1993; 23: 1711—1714.
163.
Li L., Cousart S., Hu J., McCall CECharacterization of interleukin-1 receptor associated kinase in normal and endotoxin-tolerant cells. J Biol Chem2000 ; 275: 23340—23345.
Henricson BE , Manthey CL, Perera PY, Hamilton TA, Vogel SNDissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryllipid A. Infect Immun1993; 61: 2325—2333.
166.
Blackwell TS, Blackwell TR, Christman JWImpaired activation of nuclear factor kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol1997; 158: 5934—5940.
167.
Ziegler-Heitbrock HWMolecular mechanism in tolerance to lipopolysaccharide . J Inflamm1995; 45: 13—26.
168.
Bohuslav J. , Kravchenko VV, Parry GC et al. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J Clin Invest1998; 102: 1645—1652.
169.
Seatter SC , Clair L., Bennett T., Bubrick M., West MAIndependent signal transduction pathways for IL-1 and TNF in LPS-tolerant macrophages. J Surg Res1995; 58: 651—658.
170.
Severn A., Xu D., Doyle J. et al. Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity . Eur J Immunol1993; 23: 1711—1714.
171.
Zhang X., Morrison DCLipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J Exp Med1993; 177: 511—516.
172.
Zingarelli B., Halushka PV, Caputi AP, Cook JAIncreased nitric oxide synthesis during the development of endotoxin tolerance. Shock1995; 3: 102—108
173.
Ancuta P., Fahmi H., Pons JF, Le Blay K., Chaby R.Involvement of the membrane form of tumor necrosis factor alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide. Immunology1997; 92: 259—266.
174.
Blackwell TS, Christman JWThe role of nuclearfactor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol1997; 17: 3—9.
175.
Ogle CK, Guo X., Chance WT, Ogle JDInduction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor. Crit Care Med1997 ; 25: 827—833.